FONTANA, DILETTA

FONTANA, DILETTA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 48 (tempo di esecuzione: 0.034 secondi).
Titolo Tipologia Data di pubblicazione Autori File
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
Idiopathic erythrocytosis: a germline disease? 01 - Articolo su rivista 2024 Elli, E. M.Mauri, M.D’Aliberti, D.Crespiatico, I.Fontana, D.Redaelli, S.Pelucchi, S.Spinelli, S.Manghisi, B.Cavalca, F.Aroldi, A.Ripamonti, A.Palamini, S.Mottadelli, F.Massimino, L.Ramazzotti, D.Cazzaniga, G.Piperno, A.Gambacorti-Passerini, C.Piazza, R. +
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer 02 - Intervento a convegno 2024 Crippa, VFontana, DCivettini, IMologni, LPiazza, RGambacorti Passerini, CRamazzotti, D
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape 01 - Articolo su rivista 2024 Fontana, DZambrotta, GPMPiazza, RGambacorti-Passerini, C +
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 01 - Articolo su rivista 2024 Fontana, DilettaGambacorti-Passerini, CarloPiazza, Rocco +
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 01 - Articolo su rivista 2024 Villa, MatteoMalighetti, FedericaSharma, Geeta G.Manfroni, ChiaraFontana, DilettaCordani, NicolettaMeneveri, RaffaellaPiazza, RoccoPagni, FabioCortinovis, DiegoMologni, Luca +
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 01 - Articolo su rivista 2024 Villa, MatteoSharma, Geeta G.Malighetti, FedericaMauri, MarioCordani, NicolettaPirola, AlessandraD'Aliberti, DeborahMassimino, LucaCriscuolo, LucreziaPagani, LisaChinello, CliziaMastini, CristinaFontana, DilettaBombelli, SilviaMeneveri, RaffaellaMagni, FulvioUrso, MarioPagni, FabioRamazzotti, DanielePiazza, RoccoGambacorti-Passerini, CarloMologni, Luca +
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 01 - Articolo su rivista 2024 Fontana, DMalighetti, FVilla, MZambon, AGambacorti-Passerini,CMologni, L.
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 01 - Articolo su rivista 2023 Fontana, DCrespiatico, ICrippa, VMalighetti, FVilla, MAngaroni, FAroldi, AAntoniotti, MCaravagna, GPiazza, RGraudenzi, AMologni, LRamazzotti, D +
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review 01 - Articolo su rivista 2023 Diletta FontanaElena M. ElliFabio PagniRocco Piazza
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 01 - Articolo su rivista 2022 Gambacorti-Passerini, CarloAroldi, AndreaFontana, DilettaPiazza, RoccoAntolini, Laura +
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution 02 - Intervento a convegno 2022 Fontana, DCrippa, VBassi, GD'Aliberti, DMauri, MSpinelli, SMastini, CBombelli, SCivettini, IGuglielmana, VRamazzotti, DMologni, LPiazza, RGambacorti Passerini, C +
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 02 - Intervento a convegno 2022 Elli, EMauri, MD’Aliberti, DCrespiatico, IFontana, DRedaelli, SPelucchi, SManghisi, BCavalca, FRipamonti, ARamazzotti, DPiperno, AGambacorti Passerini, CPiazza, R +
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 01 - Articolo su rivista 2022 Bossi, ElisaAroldi, AndreaBorin, Lorenza MariaVerga, LuisaFontana, DilettaCocito, FedericaManghisi, BeatriceRindone, GiovanniCavalca, FabrizioRipamonti, AlessiaAntolini, LauraPiazza, Rocco GiovanniGambacorti-Passerini, Carlo +
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution 01 - Articolo su rivista 2022 Ramazzotti, DanieleAngaroni, FabrizioMaspero, DavideMauri, MarioD’Aliberti, DeborahFontana, DilettaAntoniotti, MarcoElli, Elena MariaGraudenzi, AlexPiazza, Rocco
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 02 - Intervento a convegno 2022 Villa, MMalighetti, FArosio, GManfroni, CFontana, DCordani, NMeneveri, RZambon, APiazza, RPagni, FCortinovis, DMologni, L +
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 01 - Articolo su rivista 2022 Steidl, CarolinaAroldi, AndreaMologni, LucaCrespiatico, IlariaFontana, DilettaMastini, CristinaBorin, LorenzaPiazza, RoccoGambacorti-Passerini, Carlo +
Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage 01 - Articolo su rivista 2021 Fontana, DGambacorti Passerini, CPiazza, R
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia 01 - Articolo su rivista 2021 Fontana D.Gambacorti Passerini C.Piazza R.
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 01 - Articolo su rivista 2021 Sharma, GGVilla, MMauri, MCrespiatico, IFontana, DMastini, CMagistroni, VCeccon, MRedaelli, SMassimino, LPiazza, RGambacorti Passerini, CMologni, L +